AMP-activated protein kinase (AMPK) mediates nutrient regulation of thioredoxin-interacting protein (TXNIP) in pancreatic beta-cells

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Shaked, Maayan ^a   Ketzinel Gilad, Mali ^a   Cerasi, Erol ^a   Kaiser, Nurit ^a   Leibowitz, Gil ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CARBOHYDRATE RESPONSE ELEMENT BINDING PROTEIN; FATTY ACID; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PALMITIC ACID; THIOREDOXIN INTERACTING PROTEIN; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; CARRIER PROTEIN; DEOXYGLUCOSE; ENZYME ACTIVATOR; ISOENZYME; METFORMIN; OLEIC ACID; TXNIP PROTEIN, RAT; WBSCR14 PROTEIN, RAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ENERGY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTERIFICATION; FATTY ACID OXIDATION; IMMUNOFLUORESCENCE MICROSCOPY; METABOLIC REGULATION; MOLECULAR DYNAMICS; NONHUMAN; OXYGEN SENSING; PANCREAS ISLET BETA CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; ANIMAL; CELL NUCLEUS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENE SILENCING; HUMAN; METABOLISM; PROTEIN TRANSPORT; WISTAR RAT;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARRIER PROTEINS; CELL NUCLEUS; DEOXYGLUCOSE; ENZYME ACTIVATION; ENZYME ACTIVATORS; GENE KNOCKDOWN TECHNIQUES; GLUCOSE; HUMANS; INSULIN-SECRETING CELLS; ISOENZYMES; METFORMIN; OLEIC ACID; PALMITIC ACID; PROTEIN TRANSPORT; RATS; RATS, WISTAR;

EID: 83355170596     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028804     Document Type: Article

References (46)

1. Prentki M, Nolan CJ, (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116: 1802-1812.
2. Poitout V, Robertson RP, (2008) Glucolipotoxicity: Fuel excess and beta-cell dysfunction. Endocr Rev 29: 351-366.
3. Eizirik DL, Cardozo AK, Cnop M, (2008) The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29: 42-61.
4. Kaiser N, Leibowitz G, (2009) Failure of beta-cell adaptation in type 2 diabetes: Lessons from animal models. Front Biosci 14: 1099-1115.
5. Jonas JC, Bensellam M, Duprez J, Elouil H, Guiot Y, et al. (2009) Glucose regulation of islet stress responses and beta-cell failure in type 2 diabetes. Diabetes Obes Metab 11 (Suppl 4): 65-81.
6. Chen J, Fontes G, Saxena G, Poitout V, Shalev A, (2010) Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated beta-cell death. Diabetes 59: 440-447.
7. Ivarsson R, Quintens R, Dejonghe S, Tsukamoto K, in 't Veld P, et al. (2005) Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes 54: 2132-2142.
8. Yoshioka J, Schreiter ER, Lee RT, (2006) Role of thioredoxin in cell growth through interactions with signaling molecules. Antioxid Redox Signal 8: 2143-2151.
9. Patwari P, Higgins LJ, Chutkow WA, Yoshioka J, Lee RT, (2006) The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. J Biol Chem 281: 21884-21891.
10. Chen J, Saxena G, Mungrue IN, Lusis AJ, Shalev A, (2008) Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis. Diabetes 57: 938-944.
11. Cha-Molstad H, Saxena G, Chen J, Shalev A, (2009) Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells. J Biol Chem 284: 16898-16905.
12. Shaked M, Ketzinel-Gilad M, Ariav Y, Cerasi E, Kaiser N, et al. (2009) Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets. Diabetologia 52: 636-644.
13. Chen J, Hui ST, Couto FM, Mungrue IN, Davis DB, et al. (2008) Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes. Faseb J 22: 3581-3594.
14. Hardie DG, Pan DA, (2002) Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans 30: 1064-1070.
15. Rutter GA, da Silva Xavier G, Leclerc I, (2003) Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J 375: 1-16.
16. Kahn BB, Alquier T, Carling D, Hardie DG, (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1: 15-25.
17. Kaiser N, Corcos AP, Tur-Sinai A, Ariav Y, Cerasi E, (1988) Monolayer culture of adult rat pancreatic islets on extracellular matrix: long term maintenance of differentiated B-cell function. Endocrinology 123: 834-840.
18. Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY, (2003) Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 52: 726-733.
19. Za'tara G, Bar-Tana J, Kalderon B, Suter M, Morad E, et al. (2008) AMPK activation by long chain fatty acyl analogs. Biochem Pharmacol 76: 1263-1275.
20. Yu FX, Chai TF, He H, Hagen T, Luo Y, (2010) Thioredoxin-interacting protein (Txnip) gene expression: sensing oxidative phosphorylation status and glycolytic rate. J Biol Chem 285: 25822-25830.
21. Shao W, Yu Z, Fantus IG, Jin T, (2010) Cyclic AMP signaling stimulates proteasome degradation of thioredoxin interacting protein (TxNIP) in pancreatic beta-cells. Cell Signal 22: 1240-1246.
22. Leclerc I, Woltersdorf WW, da Silva Xavier G, Rowe RL, Cross SE, et al. (2004) Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab 286: E1023-1031.
23. Ravnskjaer K, Boergesen M, Dalgaard LT, Mandrup S, (2006) Glucose-induced repression of PPARalpha gene expression in pancreatic beta-cells involves PP2A activation and AMPK inactivation. J Mol Endocrinol 36: 289-299.
24. Nyblom HK, Sargsyan E, Bergsten P, (2008) AMP-activated protein kinase agonist dose dependently improves function and reduces apoptosis in glucotoxic beta-cells without changing triglyceride levels. J Mol Endocrinol 41: 187-194.
25. Wang X, Zhou L, Li G, Luo T, Gu Y, et al. (2007) Palmitate activates AMP-activated protein kinase and regulates insulin secretion from beta cells. Biochem Biophys Res Commun 352: 463-468.
26. Minn AH, Hafele C, Shalev A, (2005) Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis. Endocrinology 146: 2397-2405.
27. Kebede MA, Alquier T, Latour MG, Poitout V, (2009) Lipid receptors and islet function: therapeutic implications? Diabetes Obes Metab 11 (Suppl 4): 10-20.
28. Uyeda K, Repa JJ, (2006) Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab 4: 107-110.
29. Kawaguchi T, Takenoshita M, Kabashima T, Uyeda K, (2001) Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc Natl Acad Sci U S A 98: 13710-13715.
30. Kabashima T, Kawaguchi T, Wadzinski BE, Uyeda K, (2003) Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci U S A 100: 5107-5112.
31. Collier JJ, Zhang P, Pedersen KB, Burke SJ, Haycock JW, et al. (2007) c-Myc and ChREBP regulate glucose-mediated expression of the L-type pyruvate kinase gene in INS-1-derived 832/13 cells. Am J Physiol Endocrinol Metab 293: E48-56.
32. Li MV, Chang B, Imamura M, Poungvarin N, Chan L, (2006) Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module. Diabetes 55: 1179-1189.
33. Tsatsos NG, Towle HC, (2006) Glucose activation of ChREBP in hepatocytes occurs via a two-step mechanism. Biochem Biophys Res Commun 340: 449-456.
34. Davies MN, O'Callaghan BL, Towle HC, (2008) Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity. J Biol Chem 283: 24029-24038.
35. Kawaguchi T, Osatomi K, Yamashita H, Kabashima T, Uyeda K, (2002) Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J Biol Chem 277: 3829-3835.
36. Burke SJ, Collier JJ, Scott DK, (2009) cAMP opposes the glucose-mediated induction of the L-PK gene by preventing the recruitment of a complex containing ChREBP, HNF4alpha, and CBP. Faseb J 23: 2855-2865.
37. Sakiyama H, Wynn RM, Lee WR, Fukasawa M, Mizuguchi H, et al. (2008) Regulation of nuclear import/export of carbohydrate response element-binding protein (ChREBP): interaction of an alpha-helix of ChREBP with the 14-3-3 proteins and regulation by phosphorylation. J Biol Chem 283: 24899-24908.
38. Chen J, Couto FM, Minn AH, Shalev A, (2006) Exenatide inhibits beta-cell apoptosis by decreasing thioredoxin-interacting protein. Biochem Biophys Res Commun 346: 1067-1074.
39. da Silva Xavier G, Leclerc I, Salt IP, Doiron B, Hardie DG, et al. (2000) Role of AMP-activated protein kinase in the regulation by glucose of islet beta cell gene expression. Proc Natl Acad Sci U S A 97: 4023-4028.
40. Parikh H, Carlsson E, Chutkow WA, Johansson LE, Storgaard H, et al. (2007) TXNIP regulates peripheral glucose metabolism in humans. PLoS Med 4: e158.
41. Patwari P, Chutkow WA, Cummings K, Verstraeten VL, Lammerding J, et al. (2009) Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins. J Biol Chem 284: 24996-25003.
42. Lachaal M, Spangler RA, Jung CY, (1993) High Km of GLUT-2 glucose transporter does not explain its role in insulin secretion. Am J Physiol 265: E914-919.
43. Kefas BA, Cai Y, Ling Z, Heimberg H, Hue L, et al. (2003) AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J Mol Endocrinol 30: 151-161.
44. Kefas BA, Heimberg H, Vaulont S, Meisse D, Hue L, et al. (2003) AICA-riboside induces apoptosis of pancreatic beta cells through stimulation of AMP-activated protein kinase. Diabetologia 46: 250-254.
45. Riboulet-Chavey A, Diraison F, Siew LK, Wong FS, Rutter GA, (2008) Inhibition of AMP-activated protein kinase protects pancreatic beta-cells from cytokine-mediated apoptosis and CD8+ T-cell-induced cytotoxicity. Diabetes 57: 415-423.
46. Meares GP, Hughes KJ, Jaimes KF, Salvatori AS, Rhodes CJ, et al. (2010) AMP-activated protein kinase attenuates nitric oxide-induced beta-cell death. J Biol Chem 285: 3191-3200.